Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Study protocol for a randomized control trial to investigate the effectiveness of an 8-week mindfulness-integrated cognitive behavior therapy (MiCBT) transdiagnostic group intervention for primary care patients.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : BioMed Central, [2001-
    • الموضوع:
    • نبذة مختصرة :
      Background: Effective transdiagnostic treatments for patients presenting with principal or comorbid symptoms of anxiety and depression enable more efficient provision of mental health care and may be particularly suitable for the varied population seen in primary healthcare settings. Mindfulness-integrated cognitive behavior therapy (MiCBT) is a transdiagnostic intervention that integrates aspects of CBT, including exposure skills targeting avoidance, with training in mindfulness meditation skills adopted from the Vipassana or insight tradition taught by the Burmese teachers U Ba Khin and Goenka. MiCBT is distinguished from both cognitive therapy and mindfulness-based cognitive therapy by the use of a theoretical framework which proposes that the locus of reinforcement of behavior is the interoceptive experience (body sensations) that co-arises with self-referential thinking. Consequently, MiCBT has a strong focus on body scanning to develop interoceptive awareness and equanimity. Designed for clinical purposes, the four-stage systemic approach of MiCBT, comprising intra-personal (Stage 1) exposure (Stage 2), interpersonal (Stage 3), and empathic (Stage 4) skillsets, is a distinguishing feature among other mindfulness-based interventions (MBIs). The aim of this study is to investigate whether and how group MiCBT decreases depression and anxiety symptoms for patients with a range of common mental health conditions.
      Methods: Participants (n = 120) recruited via medical practitioner referral will be randomized to MiCBT or a wait-list control. Inclusion criteria are age 18-75; fluent in English and having a Kessler Psychological Distress Scale (K10) score of 20 or more. The MiCBT treatment group receive an 8-week MiCBT intervention delivered in a private psychology practice. Participants complete a suite of online self-report measures and record the amount of meditation practice undertaken each week. The control group receive usual treatment and complete the measures at the same time points. Primary outcome measures are the Depression Anxiety Stress Scale-21 (DASS-21) and K10. Analysis will use mixed-model repeated measures.
      Discussion: The potential ability of MiCBT to provide a comprehensive therapeutic system that is applicable across diagnostic groups would make it an attractive addition to the available MBIs.
      Trial Registration: This trial is registered with the Australia and New Zealand Clinical Trials Registry: ACTRN12617000061336; Date of registration: 11th January 2017.
    • Comments:
      Erratum in: BMC Psychiatry. 2020 Mar 26;20(1):136. (PMID: 32216784)
    • References:
      Behav Res Ther. 1995 Mar;33(3):335-43. (PMID: 7726811)
      J Clin Psychol. 2011 Apr;67(4):404-24. (PMID: 21254062)
      J Pers Assess. 1985 Feb;49(1):71-5. (PMID: 16367493)
      J Affect Disord. 2008 Sep;110(1-2):161-6. (PMID: 18276017)
      Behav Ther. 2009 Jun;40(2):142-54. (PMID: 19433145)
      J Consult Clin Psychol. 2010 Apr;78(2):169-83. (PMID: 20350028)
      J Health Psychol. 1999 May;4(3):357-63. (PMID: 22021603)
      Cochrane Database Syst Rev. 2010 Sep 8;(9):. (PMID: 25067907)
      Psychosom Med. 1998 Sep-Oct;60(5):625-32. (PMID: 9773769)
      J Consult Clin Psychol. 2007 Aug;75(4):513-22. (PMID: 17663606)
      Arch Gen Psychiatry. 2004 Mar;61(3):310-7. (PMID: 14993119)
      J Gerontol. 1975 Jan;30(1):85-9. (PMID: 1109399)
      J Caring Sci. 2016 Sep 01;5(3):195-204. (PMID: 27752485)
      PLoS One. 2012;7(11):e48230. (PMID: 23133619)
      Psychol Sci. 2007 Mar;18(3):233-9. (PMID: 17444920)
      Soc Cogn Affect Neurosci. 2010 Mar;5(1):11-7. (PMID: 19776221)
      J Pers Soc Psychol. 2003 Apr;84(4):822-48. (PMID: 12703651)
      Arch Gen Psychiatry. 2005 Apr;62(4):409-16. (PMID: 15809408)
      J Clin Psychol. 2006 Dec;62(12):1445-67. (PMID: 17019673)
      Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jun;3(6):501-513. (PMID: 29884281)
      J Consult Clin Psychol. 2002 Apr;70(2):275-87. (PMID: 11952186)
      Cochrane Database Syst Rev. 2012 Nov 14;11:MR000030. (PMID: 23152285)
      Brain Struct Funct. 2010 Jun;214(5-6):451-63. (PMID: 20490545)
      Behav Ther. 2014 Nov;45(6):863-71. (PMID: 25311294)
      Aust N Z J Psychiatry. 2018 Apr;52(4):365-374. (PMID: 28803484)
      JAMA Intern Med. 2014 Mar;174(3):357-68. (PMID: 24395196)
      Appl Psychol Health Well Being. 2016 Mar;8(1):85-103. (PMID: 26970111)
      Curr Opin Psychiatry. 2012 Nov;25(6):522-8. (PMID: 22992547)
      Assessment. 2004 Sep;11(3):191-206. (PMID: 15358875)
      Psychiatry Clin Neurosci. 2006 Dec;60(6):718-26. (PMID: 17109706)
      BMC Public Health. 2011 Feb 24;11:131. (PMID: 21349184)
      Psychiatr Clin North Am. 2010 Sep;33(3):557-77. (PMID: 20599133)
      Assessment. 2006 Mar;13(1):27-45. (PMID: 16443717)
      J Am Acad Child Adolesc Psychiatry. 2005 Oct;44(10):1005-14. (PMID: 16175105)
      Psychol Health Med. 2009 Jan;14(1):1-8. (PMID: 19085307)
      Br J Clin Psychol. 2003 Jun;42(Pt 2):111-31. (PMID: 12828802)
      Soc Cogn Affect Neurosci. 2013 Dec;8(8):911-7. (PMID: 22933520)
      Gen Hosp Psychiatry. 1982 Apr;4(1):33-47. (PMID: 7042457)
      Drug Alcohol Depend. 2011 Aug 1;117(1):78-81. (PMID: 21277705)
      JAMA Psychiatry. 2014 Oct;71(10):1192-3. (PMID: 25103620)
      J Behav Med. 2012 Jun;35(3):262-71. (PMID: 21667281)
      PLoS One. 2017 May 24;12(5):e0176239. (PMID: 28542181)
      Depress Anxiety. 2010;27(1):78-89. (PMID: 19569060)
      Behav Ther. 2007 Sep;38(3):234-46. (PMID: 17697849)
      J Behav Med. 1985 Jun;8(2):163-90. (PMID: 3897551)
      Clin Psychol Rev. 2006 Jan;26(1):17-31. (PMID: 16199119)
      J Anxiety Disord. 2007;21(7):931-43. (PMID: 17257810)
      Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20254-9. (PMID: 22114193)
      Psychosom Med. 2000 Sep-Oct;62(5):613-22. (PMID: 11020090)
      Perspect Psychol Sci. 2015 Sep;10(5):599-617. (PMID: 26385999)
      J Pers Assess. 2010 Mar;92(2):116-27. (PMID: 20155561)
      Br J Clin Psychol. 2005 Jun;44(Pt 2):227-39. (PMID: 16004657)
      BMC Complement Altern Med. 2014 Mar 11;14:95. (PMID: 24612825)
      Psychol Med. 2002 Aug;32(6):959-76. (PMID: 12214795)
    • Contributed Indexing:
      Keywords: Anxiety; Depression; Equanimity; Group therapy; MiCBT; Mindfulness; Mindfulness-based intervention; Mindfulness-integrated cognitive behavior therapy; Transdiagnostic
    • الموضوع:
      Date Created: 20200108 Date Completed: 20201019 Latest Revision: 20210110
    • الموضوع:
      20221213
    • الرقم المعرف:
      PMC6945698
    • الرقم المعرف:
      10.1186/s12888-019-2411-1
    • الرقم المعرف:
      31906903